Business
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a
About this update from Prenetics Global Limited
[{"type":"text","content":"CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (\"Prenetics\" or the \"Company\"), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced that all key members of its executive leadership team have executed open market purchases of Prenetics’ common stock during the Company’s designated trading window. In total, the executive team acquired 111,911 shares of Prenetics’ common stock for an aggregate purchase price of approximately $1,446,887. Individual Transaction Details Danny Yeung, Chief Executive OfficerIn two open market transactions on November 18 and 19, Mr. Yeung acquired a total of 40,118 shares for a total purchase price of approximately $502,000, at an average price of approximately $12.51 per share. Rahul Ramchand, Chief Marketing OfficerIn two open market transactions on November 12 and 14, Mr. Ramchand acquired a total of 60,000 shares for a total purchase price of approximately $793,972, at an average price of approximately $13.23 per share. Stephen Lo, Chief Financial OfficerIn an open market transaction on November 21, Mr. Lo acquired 8,000 shares for a total purchase price of approximately $100,915, at an average purchase price of approximately $12.61 per share. David Vanderveen, President of AmericasIn an open market transaction on November 20, Mr. Vanderveen acquired 3,793 shares for a total purchase price of approximately $50,000, at an average purchase price of approximately $13.15 per share. Danny Yeung, CEO of Prenetics, commented:“These purchases reflect our collective conviction in the long-term vision of Prenetics and IM8. With IM8 scaling rapidly as one of the fastest-growing wellness brands globally and our Bitcoin-treasury strategy reinforcing long-term financial resilience, our executive team is fully aligned with shareholders. We believe Prenetics is still in the early innings of unlocking its true value, and we are investing personally because we see an exceptional future ahead.” This press release is being furnished as an exhibit to a Form 6-K that will be filed with the U.S. Securities and Exchange Commission. About PreneticsPrenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its fl...